Holm-Yildiz Sonja, Krag Thomas, Dysgaard Tina, Pedersen Britt Stævnsbo, Witting Nanna, Kodal Louise Sloth, Kannuberg Linda, Pedersen Jonas Jalili, Andersen Rebecca Kjær, Lyu Zhe, Aagaard Morten Müller, Vissing Christoffer Rasmus, Dahlqvist Julia, Løkken Nicoline, Poulsen Nanna Scharff, Vissing John
Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Muscle Nerve. 2025 Mar;71(3):360-367. doi: 10.1002/mus.28330. Epub 2024 Dec 24.
INTRODUCTION/AIMS: Primary hypokalemic periodic paralysis (HypoPP) can present with periodic paralysis and/or permanent muscle weakness. Permanent weakness is accompanied by fat replacement of the muscle. It is unknown whether the permanent muscle weakness is solely due to fat replacement or if other factors affect the ability of the remaining muscle fibers to contract. We aimed to investigate muscle fat replacement and contractility in persons with HypoPP-causing variants in CACNA1S and to compare the results to healthy controls.
In this cross-sectional study, we used T1-weighted and 2-point Dixon magnetic resonance imaging (MRI) to assess fat replacement of the muscle and stationary dynamometry to assess muscle strength. Contractility was determined by maximal muscle contraction divided by the contractile cross-sectional muscle area.
We included 45 persons with HypoPP-causing variants in CACNA1S and data from 37 healthy controls. We found that fat fraction was increased in ankle dorsiflexors and knee extensors and flexors, and further found that muscle strength was decreased in knee extensors and flexors in persons with HypoPP-causing variants in CACNA1S compared to healthy controls. Additionally, we found decreased contractility of thigh muscles in persons with HypoPP-causing variants in CACNA1S compared to healthy controls.
The decreased contractility could relate to skeletal muscle voltage-gated calcium channel dysfunction, subclinical attacks of paralysis, and/or changed muscle architecture, but this needs further investigation.
引言/目的:原发性低钾性周期性麻痹(HypoPP)可表现为周期性麻痹和/或永久性肌肉无力。永久性肌无力伴有肌肉脂肪替代。目前尚不清楚永久性肌肉无力是否仅由脂肪替代引起,还是其他因素影响了剩余肌纤维的收缩能力。我们旨在研究携带CACNA1S基因致病变异的HypoPP患者的肌肉脂肪替代和收缩性,并将结果与健康对照进行比较。
在这项横断面研究中,我们使用T1加权和两点Dixon磁共振成像(MRI)评估肌肉的脂肪替代情况,并使用静态测力计评估肌肉力量。收缩性通过最大肌肉收缩量除以收缩性横截面积来确定。
我们纳入了45例携带CACNA1S基因致病变异的HypoPP患者以及3名健康对照的数据。我们发现,踝关节背屈肌、膝关节伸肌和屈肌的脂肪分数增加,并且还发现,与健康对照相比,携带CACNA1S基因致病变异的HypoPP患者的膝关节伸肌和屈肌力量下降。此外,我们发现,与健康对照相比,携带CACNA1S基因致病变异的HypoPP患者大腿肌肉的收缩性降低。
收缩性降低可能与骨骼肌电压门控钙通道功能障碍、亚临床麻痹发作和/或肌肉结构改变有关,但这需要进一步研究。